Corresponding Author: Sonia Michail, MD, FAAP, AAGAF ORCID iD Address: Professor of Clinical Pediatrics, Keck School of Medicine, Director of Inflammatory Bowel Disease Research, Children’s Hospital of Los Angeles, 4650 Sunset Blvd MS#78, Los Angeles CA, 90027, USA. Received date: 31 January 2021; Accepted date: 22 February 2021; Published date: 01 March 2021
Citation: Rotondo-Trivette S, Michail S. Pediatric Inflammatory Bowel Disease. Asp J Pediatrics Child Health. 2021 Mar 01;3(1):11-17.
Inflammatory bowel disease is an important pediatric disease, with as many as 25% of cases presenting during childhood. In this article, we review the types, etiology epidemiology, presentation, diagnosis, and management of pediatric inflammatory bowel disease. We also highlight the unique aspects of pediatric-onset inflammatory bowel disease versus adult-onset and future directions in this field, such as the use of genetic studies and ultrasound for the management of pediatric patients with inflammatory bowel disease.
Pediatric-onset inflammatory bowel disease is unique from adult-onset, and has several different categories based on age of diagnosis.
Pediatric patients with inflammatory bowel disease may struggle with growth delays and psychosocial impacts of their disease; multidisciplinary management with dietitians and mental health professionals may be warranted.
HLA typing and the use of ultrasound in pediatric inflammatory bowel disease may mitigate the risk of treatment failure and exposure to invasive procedures over the course of a child’s disease.